Multitherapy - Infusion Pumps

The contract seeks the procurement of ten ambulatory infusion pumps to support the Department of Hematology/Oncology at William Beaumont Army Medical Center, with delivery required at Fort Bliss, Texas. These pumps are essential for enabling chemotherapy administration in home settings, enhancing patient mobility and reducing the frequency of clinical visits. The solicitation, identified as W81K0026QA201, was posted on June 23, 2026, with responses due by June 29, 2026. It is a commercial item acquisition under FAR 52.212-4 with Alternate I and Deviation 2026-O0038, employing a Lowest Price Technically Acceptable (LPTA) evaluation methodology. Offerors must demonstrate technical acceptability by meeting all specified salient characteristics outlined in the attached two-page specification document; failure to meet any requirement, submitting a proposal exceeding ten pages, or providing insufficient detail results in automatic disqualification. Award will be made to the lowest-priced technically acceptable offer without trade-offs between cost and performance, resulting in a Firm-Fixed-Price purchase order. The contract imposes stringent compliance requirements aligned with Department of Defense security and procurement policies. Contractors must adhere to NIST SP 800-171 for safeguarding covered defense information and comply with 252.204-7008 and 252.204-7018 on cybersecurity controls and prohibitions against acquiring telecommunications equipment from designated foreign adversaries. Item-level identification under MIL-STD-130 using two-dimensional data matrix symbology is mandatory, along with shipment labeling conforming to MIL-STD-129. All deliveries must be shipped FOB destination with transportation costs borne by the contractor. Invoicing must be submitted electronically via Wide Area WorkFlow, and payment will be processed using DoDAAC codes HT0490 and W81K00. The contract requires full implementation of federal procurement policies including Buy American Act compliance, prohibition of hexavalent chromium, exclusion of entities tied to the Maduro regime or Xinjiang Uyghur Autonomous Region, and adherence to whistleblower protections. Offerors must validate their unique entity identifier and CAGE code in SAM, represent their small business status if applicable, and disclose ownership structures and any affiliations with inverted domestic corporations or covered telecommunications equipment. All submissions must be emailed to Kacie Burris and Jaclyn Evans by the deadline, with failure to